At the Crossroads of Molecular Biology and Immunology: Molecular Pathways for Immunological Targeting of Head and Neck Squamous Cell Carcinoma

Background: Recent advances in immunotherapy for head and neck squamous cell carcinoma (HNSCC) have led to implementation of anti-programmed death receptor 1 (PD-1) immunotherapy to standard of care for recurrent/metastatic HNSCC. However, the majority of tumors do not respond to these therapies, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wondergem, Niels E., Nijenhuis, Dennis N. L. M., Poell, Jos B., Leemans, C. René, Brakenhoff, Ruud H., van de Ven, Rieneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oral Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757702/
https://www.ncbi.nlm.nih.gov/pubmed/35047999
http://dx.doi.org/10.3389/froh.2021.647980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757702/
https://www.ncbi.nlm.nih.gov/pubmed/35047999
http://dx.doi.org/10.3389/froh.2021.647980

Ejemplares similares